Blood Pressure

Cardiovascular

18 drugs in development·12 companies·4 clinical trials

Drug Pipeline by Phase

Approved(16)

Drug	Company
amlodipine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
candesartan cilexetil	Aptinyx Inc. (APTX)
exforge	Novartis AG (NVS)
exforge hct	Novartis AG (NVS)
felodipine	Mylan II B.V. (MYL)
GIAPREZA®	Innoviva, Inc. (INVA)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
losartan	Mylan II B.V. (MYL)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
norepinephrine bi	Amneal Pharmaceuticals, Inc. (AMRX)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
sodium nitroprusside	NEXUS BIOPHARMA INC (NEXS)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
telmisartan	Inventiva S.A. (IVA)
valsartan	Mylan II B.V. (MYL)
vasopressin	Amphastar Pharmaceuticals, Inc. (AMPH)

Phase 1(1)

Drug	Company
hjb647	Novartis AG (NVS)

Preclinical(1)

Drug	Company
cleviprex	SCICLONE PHARMACEUTICALS INC (SCLN)

BioSniper tracks 18 drugs in development for Blood Pressure across 12 companies.

There are 4 clinical trials targeting Blood Pressure tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.